S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Relay Therapeutics Inc (RLAY)
Relay Therapeutics Inc (RLAY) Financials

RLAY Relay Therapeutics Inc

6.41

0.11 (1.75%)

May 31 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-22.764	-18.33	-38.595	-40.245	-27.56	-35.187
Return on Equity (%)	87.959	51.691	-78.991	-43.811	-31.44	-40.18
Return on Invested Capital (%)	-23.739	-21.64	-9.974	-44.003	-32.479	-43.962
Operating Margin (%)	N/A	N/A	-63.411	-12012.942	-21036.133	-1338.656
Net Profit Margin (%)	N/A	N/A	-278.512	-12012.942	-21036.133	-1338.656
Book Value Per Share	39.567	24.926	8.49	9.951	7.827	6.082
Earnings Per Share	-4.583	-5.253	-2.56	-4.043	-2.399	-2.774
Cash Per Share	39.597	2.926	4.979	3.113	1.253	1.166
Working Capital Per Share	39.196	24.313	8.414	10.578	7.892	6.002
Operating Profit Per Share	N/A	N/A	0.919	0.034	0.108	0.259
EBIT Per Share	-4.583	-5.253	-0.583	-4.043	-2.399	-2.774
EBITDA Per Share	-4.583	-5.253	-0.583	-4.043	-2.399	-2.774
Free Cash Flow Per Share	-4.627	-4.893	-2.578	-4.048	-2.358	-2.783

Liquidity Ratios

Year End December 30 2023	2018	2019	2020	2021	2022	2023
Current Ratio	61.777	30.08	56.492	40.14	16.003	25.442
Quick Ratio	61.399	29.686	55.242	39.409	15.684	24.781
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	10.65M	14.34M	89.91M	89.99M	121.11M	N/A

Key Stats and Ratios

Year End December 30 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	108.81M	120.81M	121.11M	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	-41698.673	N/A	N/A	N/A	-813.301
Net Profit Margin (%)	N/A	N/A	N/A	-41698.673	N/A	N/A	N/A	-813.301
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	13.601	N/A	N/A	N/A	20.733
Quick Ratio	N/A	N/A	N/A	13.312	N/A	N/A	N/A	20.181
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	842.17M
Price to Earnings Ratio	-2.46
Price to Sales Ratio	26.34
Price to Cash Ratio	5.86
Price to Book Ratio	1.12
Dividend Yield	-

Share Statistics

Shares Outstanding	131.18M
Average Volume (1 week)	1.06M
Average Volume (1 Month)	1.27M
52 Week Change	-41.62%
52 Week High	13.32
52 Week Low	5.70

More Ratios Coming Soon!

Relay Therapeutics

Tianjin Port Development (PK)

Agios Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions